Keyphrases
Gefitinib
100%
Radiosensitization
100%
Non-small Cell Lung Cancer Cells
100%
Ataxia Telangiectasia mutated
100%
A549 Cells
66%
NCI-H460
44%
Cyclooxygenase-2
33%
Ionizing Radiation
33%
Multinucleated Cells
33%
Ionizing Radiation Effects
33%
Overexpression
22%
NCI-H460 Cells
22%
Radiation Effects
11%
Non-small Cell Lung Cancer (NSCLC)
11%
Radiation Therapy
11%
Epidermal Growth Factor Receptor
11%
Non-small Cell Lung Cancer Patients
11%
Specific Inhibitor
11%
Epidermal Growth Factor Receptor Inhibitors
11%
Human Lung Cancer Cell Line
11%
Mitotic Cell Death
11%
Clonogenic Survival
11%
Multinucleation
11%
γH2AX Foci
11%
Medicine and Dentistry
Cancer Cell
100%
Non Small Cell Lung Cancer
100%
Gefitinib
100%
Ataxia Telangiectasia
100%
Ionizing Radiation
66%
Radiation Exposure
33%
Radiosensitization
22%
Cell Death
11%
Radiation Therapy
11%
Epidermal Growth Factor Receptor
11%
Epidermal Growth Factor Receptor Kinase Inhibitor
11%
Mitosis
11%
Lung Cancer Cell Line
11%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Gefitinib
100%
Ataxia Telangiectasia
100%
Ionizing Radiation
66%
Radiation Exposure
33%
Epidermal Growth Factor Receptor
11%
Epidermal Growth Factor Receptor Kinase Inhibitor
11%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Gefitinib
100%
Ataxia Telangiectasia Mutated
100%
Epidermal Growth Factor Receptor
22%
Radiosensitization
22%
Cell Death
11%
Mitosis
11%
Growth Factor Receptor Inhibitor
11%